Balchem Corp Stock Price, News & Analysis

Balchem (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, has announced its participation in the HC Wainwright & Co. 26th Annual Global Investment Conference on September 9, 2024. The company will be represented by key executives including Ted Harris (Chairman of the Board, President and CEO), Martin Bengtsson (CFO), and Allison Baurichter (Senior Director Investor Relations).

This presentation at a prominent investment conference provides an opportunity for Balchem to showcase its business strategies, financial performance, and growth prospects to potential investors and industry analysts. The event could potentially impact Balchem's stock performance and investor relations.

Balchem (NASDAQ: BCPC) reported strong Q2 2024 financial results with record earnings from operations and adjusted EBITDA. Key highlights include:

- Net sales of $234.1 million, up 1.2% YoY
- Adjusted EBITDA of $62.3 million, up 5.0% YoY
- GAAP net earnings of $32.1 million, up 6.5% YoY
- GAAP EPS of $0.98, compared to $0.93 in Q2 2023
- Record adjusted EPS of $1.09, up from $1.06 in Q2 2023
- Free cash flow of $38.4 million

The Human Nutrition & Health and Specialty Products segments showed strong performance with record earnings. Balchem also launched Optifolin+®, a new choline-enriched folate ingredient. The company's net debt decreased to $202.8 million, with a leverage ratio of 0.9x.

Balchem (NASDAQ: BCPC) will hold a conference call on Friday, July 26, 2024, at 11:00 AM Eastern Time (ET) to discuss second quarter financial results. The results will be published earlier that day before the market opens. Ted Harris, Chairman, President, and CEO, along with CFO Martin Bengtsson, will lead the call. The press release and financial exhibits will be available on the company's website. The call can be accessed toll-free at 1-877-407-8289, with a replay available until August 9, 2024.

Balchem (NASDAQ: BCPC), a global specialty ingredient manufacturer, will present at the CJS Securities 24th Annual New Ideas Summer Conference on July 10, 2024. The event is set to take place in Montvale, NJ. Ted Harris, Chairman, President, and CEO, along with CFO Martin Bengtsson and Senior Director of Investor Relations Allison Baurichter, will represent the company. This presentation highlights Balchem's commitment to engaging with investors and showcasing its market position in the health and nutrition sectors.

Balchem (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced it will present at the Wells Fargo Industrials Conference on June 12, 2024. The presentation will be made by Ted Harris, the Chairman of the Board, President, and CEO; Martin Bengtsson, the CFO; and Allison Baurichter, the Senior Director of Investor Relations. This conference attendance is expected to provide Balchem with a platform to discuss its latest strategies and developments with industry peers and investors.

Balchem (NASDAQ: BCPC) announced that they will attend the Deutsche Bank Global Consumer Conference on June 4, 2024, in Montvale, NJ. The company specializes in manufacturing specialty ingredients for health and nutrition markets.

Representing Balchem at the conference will be Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO. This event will provide an opportunity for the company to engage with investors and industry stakeholders.

Balchem (NASDAQ: BCPC) reported record net sales of $239.7 million, net earnings of $29.0 million, adjusted EBITDA of $60.9 million, and free cash flow of $26.8 million for the first quarter of 2024. The Human Nutrition & Health segment saw significant growth, with sales up 15.1% and earnings up 80.4% compared to the prior year. The Animal Nutrition & Health segment experienced a decrease in sales, while the Specialty Products segment remained stable. The company's strong financial performance and sustainability initiatives signal a positive outlook for 2024.

The New York Jets have announced a multi-year partnership with VitaCholine, a Balchem Human Nutrition and Health brand, marking VitaCholine's first sponsorship and the first sponsorship in the Nutritional Ingredient category of a major professional sports team. The agreement includes territorial rights in the United States and the United Kingdom, entitlement of the New York Jets official website, and presenting partner status for a Jets road game. VitaCholine will be featured prominently on the team's website and at MetLife Stadium, aiming to raise awareness about the essential nutrient choline and its health benefits. This collaboration highlights the growing demand for solutions supporting mental and physical performance in the post-pandemic era.

Balchem (BCPC) will attend the BMO 19th Annual Global Farm to Market Conference on May 16, 2024. The conference will be attended by top executives, including Chairman Ted Harris, CFO Martin Bengtsson, and Senior Director Investor Relations Allison Baurichter.